Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Breil, Thomas [VerfasserIn]   i
 Kneppo, Carolin [VerfasserIn]   i
 Bettendorf, Markus [VerfasserIn]   i
 Müller, Hermann L. [VerfasserIn]   i
 Kapelari, Klaus [VerfasserIn]   i
 Schnabel, Dirk [VerfasserIn]   i
 Woelfle, Joachim [VerfasserIn]   i
Titel:Sequential measurements of IGF-I serum concentrations in adolescents with Laron syndrome treated with recombinant human IGF-I (rhIGF-I)
Verf.angabe:Thomas Breil, Carolin Kneppo, Markus Bettendorf, Hermann L. Müller, Klaus Kapelari, Dirk Schnabel, Joachim Woelfle
E-Jahr:2018
Jahr:11.07.2018
Umfang:8 S.
Fussnoten:Gesehen am 15.08.2019
Titel Quelle:Enthalten in: The journal of pediatric endocrinology and metabolism
Ort Quelle:Berlin [u.a.] : de Gruyter, 1985
Jahr Quelle:2018
Band/Heft Quelle:31(2018), 8, Seite 895-902
ISSN Quelle:2191-0251
Abstract:Background: Recombinant human insulin-like growth factor 1 (rhIGF-I) has been approved as an orphan drug for the treatment of growth failure in children and adolescents with severe primary IGF-I deficiency (SPIGFD) with little pharmacokinetic data available. Therefore, sequential measurements of serum IGF-I, glucose, potassium, insulin and cortisol were performed in patients treated with rhIGF-I to evaluate their significance in safety and efficacy. Methods: Repetitive blood samples were taken after meals before and 30, 60, 120, 180 and 360 min after rhIGF-I injections in two male patients with Laron syndrome at times of dose adjustments. Results: Maximal IGF-I concentrations were observed 2 h after injections (495 ng/mL) and concentrations were still higher 6 h after injections than at baseline (303 ng/mL vs. 137 ng/mL). Thirteen percent of all and 33% of maximum IGF-I concentrations were greater than +2 standard deviation score (SDS) calculated for bone age (BA) (IGF-I SDS BA) rather than chronological age (CA) as BA was significantly delayed to CA by 3.2 years (p=0.0007). Height velocities correlated with individual maximum IGF-I SDS BA (ρ=0.735; p<0.0001). Serum insulin, cortisol and glucose did not correlate with IGF-I concentrations, but serum potassium showed a negative correlation (ρ=−0.364; p<0.0001) with IGF-I concentrations. Conclusions: Sequential measurements of serum IGF-I, glucose and potassium in patients with Laron syndrome may aid in optimizing and individualizing rhIGF-I treatment. IGF-I concentrations should be referenced according to BA which better reflects the biological age. The inverse correlation of IGF-I and serum potassium concentrations after injections of rhIGF-I has not been reported before and warrants further consideration.
DOI:doi:10.1515/jpem-2018-0139
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1515/jpem-2018-0139
 DOI: https://doi.org/10.1515/jpem-2018-0139
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1665915196
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68420987   QR-Code
zum Seitenanfang